| related words |
| nexavar |
| syndrome |
| liver |
| laboratory |
| designation |
| influenza |
| bovine |
| halted |
| warning |
| credibility |
| melafind |
| cancer |
| predominantly |
| incidence |
| hormone |
| feraheme |
| soliris |
| surgeon |
| orphan |
| allegedly |
|
| related documents |
| 716646--6/14/2010--CLINICAL_DATA_INC |
| 883975--3/11/2010--STEMCELLS_INC |
| 1312069--2/16/2010--FOUR_RIVERS_BIOENERGY_INC. |
| 716646--6/15/2009--CLINICAL_DATA_INC |
| 883975--3/16/2009--STEMCELLS_INC |
| 310158--2/27/2009--SCHERING_PLOUGH_CORP |
| 883975--3/14/2008--STEMCELLS_INC |
| 310158--2/29/2008--SCHERING_PLOUGH_CORP |
| 934473--3/17/2008--GENVEC_INC |
| 1162192--3/31/2008--AVALON_PHARMACEUTICALS_INC |
| 16160--8/16/2007--CAL_MAINE_FOODS_INC |
| 883975--3/15/2007--STEMCELLS_INC |
| 934473--3/16/2007--GENVEC_INC |
| 1162192--3/30/2007--AVALON_PHARMACEUTICALS_INC |
| 883975--3/16/2006--STEMCELLS_INC |
| 1162192--3/31/2006--AVALON_PHARMACEUTICALS_INC |
| 16160--8/17/2006--CAL_MAINE_FOODS_INC |
| 1028215--10/14/2010--KMG_CHEMICALS_INC |
| 924642--4/1/2010--DIGITAL_ANGEL_CORP |
| 1183765--3/8/2010--THRESHOLD_PHARMACEUTICALS_INC |
|
| related topics |
| {product, liability, claim} |
| {operation, natural, condition} |
| {product, candidate, development} |
| {loan, real, estate} |
| {regulation, government, change} |
| {customer, product, revenue} |
| {interest, director, officer} |
| {tax, income, asset} |
| {provision, law, control} |
| {control, financial, internal} |
| {property, intellectual, protect} |
| {product, market, service} |
| {financial, litigation, operation} |
| {cost, regulation, environmental} |
| {cost, contract, operation} |
| {cost, operation, labor} |
| {debt, indebtedness, cash} |
| {stock, price, operating} |
| {condition, economic, financial} |
| {capital, credit, financial} |
|